ベトナムインフルエンザワクチン市場規模、シェア、競争環境およびトレンド分析レポート：ワクチンの種類別（不活化インフルエンザワクチン、弱毒生インフルエンザワクチン）、インフルエンザの種類別（季節性、パンデミック）、製剤別（三価、四価）、技術別（卵培養卵培養、細胞培養、組み換え）、年齢層別（小児、成人)、投与経路別(筋肉内注射、鼻腔スプレー)、流通チャネル別(病院、小売薬局、政府供給機関、その他)： 2025年から2033年までの機会分析および業界予測
レポートID : ROJP0225483 |
発行日 : 2025年02月 |
フォーマット : 
: 
: 
無料サンプル
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Impact of Covid-19 on Vietnam Influenza Vaccine Market
4. Executive Summary
5. Vietnam Influenza Vaccine Market Outlook, 2025-2033
5.1. Market Size & Forecast
5.1.1.By Value
5.1.2.By Volume
5.1. By Type of Vaccine
5.1.1. Inactivated Influenza Vaccine
5.1.2. Live Attenuated Influenza Vaccine
5.2. By Type of Influenza
5.2.1.Seasonal
5.2.2.Pandemic
5.3. By Formulation
5.3.1. Trivalent
5.3.1.1. Standard Dose Unadjuvanted
5.3.1.2. High Dose Unadjuvanted
5.3.1.3. Adjuvanted
5.3.2. Quadrivalent
5.3.2.1. Standard Dose Unadjuvanted
5.3.2.2. Unadjuvanted
5.4. By Technology
5.4.1. Egg-based
5.4.2. Cell culture
5.4.3. Recombinant
5.5. By Age Group
5.5.1. Paediatric
5.5.2. Adult
5.6. By Route of Administration
5.6.1. Intra-muscular injection
5.6.2. Nasal Spray
5.7. By Distribution Channel
5.7.1. Hospital
5.7.2. Retail Pharmacies
5.7.3. Government Suppliers
5.7.4. Others
5.8. By Region
5.8.1. Northern
5.8.2. Central
5.8.3. Southern
5.9. By Company Market Share (%), 2025
6. Market Mapping, 2025
7.1. By Type of Vaccine
7.2. By Type of Influenza
7.3. By Formulation
7.4. By Technology
7.5. By Age Group
7.6. By Route of Administration
7.7. By Distribution Channel
7.8. By Region
8. Macro Environment and Industry Structure
8.1. Demand Supply Analysis
8.2. Import Export Analysis
8.3. Value Chain Analysis
8.4. PESTEL Analysis
8.4.1. Political Factors
8.4.2. Economic System
8.4.3. Social Implications
8.4.4. Technological Advancements
8.4.5. Environmental Impacts
8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
8.5. Porter’s Five Forces Analysis
8.5.1. Supplier Power
8.5.2. Buyer Power
8.5.3. Substitution Threat
8.5.4. Threat from New Entrant
8.5.5. Competitive Rivalry
9. Market Dynamics
9.1. Growth Drivers
9.2. Growth Inhibitors (Challenges and Restraints)
10. Regulatory Framework and Innovation
10.1 Clinical Trials
10.2 Patent Landscape
10.3 Regulatory Approvals
10.4 Innovations/Emerging Technologies
11. Key Players Landscape
11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)
12. Pricing Analysis
13. Case Studies
14. Key Players Outlook
14.1. Sanofi Pasteur Inc.
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Financials (As reported)
14.1.5. Key Market Focus & Geographical Presence
14.1.6. Recent Developments
14.2. GlaxoSmithKline PLC.
14.3. Abbott Healthcare Pvt. Ltd.
14.4. Novartis AG
14.5. AstraZeneca PLC.
14.6. Merck & Co.
14.7. Johnson and Johnson Services Inc.
14.8. Novavax, Inc.
14.9. F. Hoffmann-La Roche Ltd.
14.10. CSL Limited. (Seqirus)
14.11. Vabiotech
15. Strategic Recommendations
16. About Us & Disclaimer
無料サンプルを入手する 
この無料サンプルには、トレンド分析から推定・予測まで、さまざまなデータが含まれています。
最新レポート
お問い合わせ
-
- JAPAN : 03-6899-2648
-
- EMAIL : [email protected]
